APA (7th ed.) Citation

Avila-Herrera, A., Kimbrel, J. A., Manuel Martí, J., Thissen, J., Saada, E. A., Weisenberger, T., . . . Borucki, M. K. (2024). Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies. PLoS ONE, 19(1), 1. https://doi.org/10.1371/journal.pone.0289198

Chicago Style (17th ed.) Citation

Avila-Herrera, Aram, et al. "Differential Laboratory Passaging of SARS-CoV-2 Viral Stocks Impacts the in Vitro Assessment of Neutralizing Antibodies." PLoS ONE 19, no. 1 (2024): 1. https://doi.org/10.1371/journal.pone.0289198.

MLA (9th ed.) Citation

Avila-Herrera, Aram, et al. "Differential Laboratory Passaging of SARS-CoV-2 Viral Stocks Impacts the in Vitro Assessment of Neutralizing Antibodies." PLoS ONE, vol. 19, no. 1, 2024, p. 1, https://doi.org/10.1371/journal.pone.0289198.